Physician
Gastroenterology
Dr. Dilip K. Moonka, MD
|
|
Give Review
Dilip Moonka is an expert in the field of Gastroenterology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Dilip Moonka has written publications. He has 46 publications published with PubMed. The lastest paper is: 'Quantitative assessment of hepatitis C virus RNA in peripheral blood mononuclear cells during therapy with interferon-alpha2a.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation.
- Incidence of cardiovascular and cerebrovascular events associated with sirolimus use after liver transplantation.
- Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
- Beyond survival: how well do transplanted livers work? A preliminary comparison of standard-risk, high-risk, and living donor recipients.
- Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation.
- Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
- Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome.
- Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection.
- Impact of aberrant arterial anatomy and location of anastomosis on technical outcomes after liver transplantation.
- The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors.
- Living donor and split-liver transplantation: an overview.
- A pilot trial of recombinant interleukin-12 in patients with chronic hepatitis C who previously failed treatment with interferon-alpha.
- Recurrent disease after liver transplantation.
- Successful strategy for reducing biliary complications after liver transplantation.
- The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
- High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome.
- CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells.
- Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.
- Extracorporeal photopheresis alone and with interferon-alpha2a in chronic hepatitis C patients who failed previous interferon therapy.
- Quantitation of hepatitis C virus RNA in liver tissue of allografts: correlation with histologic features and liver function tests.
- Quantitative assessment of hepatitis C virus RNA in peripheral blood mononuclear cells during therapy with interferon-alpha2a.
- Pouchitis associated with primary cytomegalovirus infection.
- cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C.
- Giant gastric ulcers: an unusual manifestation of Crohn's disease.
- A consensus primer to amplify both alpha and beta chains of the human T cell receptor.
- A human alloreactive inducer T cell clone that selectively activates antigen-specific suppressor T cells.
- Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative...
- Peliosis hepatis: old disease, new cause.
- Arteriovenous malformation of the small bowel diagnosed with enteroclysis.
- The influence of induction therapy on graft and patient survival in patients with and without hepatitis C after liver transplantation.
- Renal disease burden following liver transplantation.
- Influence of hepatitis C on renal function after liver transplantation.
- Long-term management of the liver transplant patient: recommendations for the primary care doctor.
- Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes.
- Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
- Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
- The impact of donor race on recurrent hepatitis C after liver transplantation.
- Survival after liver transplantation in patients who develop renal insufficiency.
- The influence of alcohol abuse history on the differential, longitudinal patterns of mental and physical quality of life following liver transplantation.
- Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease.
- Risk for renal cell carcinoma in chronic hepatitis C infection.
- Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
- Hepatitis C virus-specific T-cell gamma interferon and proliferative responses are more common in perihepatic lymph nodes than in peripheral blood or liver.
- Model for end-stage liver disease (MELD) exception for polycystic liver disease.
- Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era.
Schools
Stanford University School Of Medicine
Stanford University
University Penn Med Center
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Intestinal Transplant
- Liver Biopsy
- View All
Doctors Specialties
- Gastroenterology
- Hepatology
- Transplant Hepatology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
Stanford University School of Medicine
Hospital
-
Henry Ford Hospital
Drug Facts
| NPI NUMBER | 1982772430 | |
| NPPES Provider LastName | MOONKA | |
| NPPES Provider FirstName | DILIP | |
| NPPES Provider ZIPCode | 48202 | |
| NPPES Provider State | MI | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 2097.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 0.91 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982772430 |
| Last Name Of The Provider | MOONKA |
| First Name Of The Provider | DILIP |
| View All |
Similar Doctors
|
Dr. Omar Sharif, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali T. Nawras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Osama H. Alaradi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vinay K. Katukuri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Dempsey, MD |
|
|
Dr. Nikhil J. Shastri, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yakir Muszkat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhavish J. Shah, MD |
|
|
Dr. Mazen Elatrache, MD |
|
|
Dr. Humberto C. Gonzalez, MD |
|
Dr. Cyrus R. Piraka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eduardo Castillo Del Castillo, MD |
|
|
Dr. Dora R. Montezuma Calvo, MD |
|
|
Dr. Suhag Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Rabin, MD |